KSAT 12: San Antonio doctor involved in remdesivir trial says FDA emergency approval is ‘very exciting’

Drs. Thomas Patterson, chief of the Division of Infectious Diseases, and Jason Bowling, Infectious Diseases, explained the implications of the FDA fast-tracking emergency authorization of the new anti-viral drug, remdesivir, as the new standard of care for hospitalized COVID-19 patients.

Read and watch the full story.



Share This Article!
Article Categories: COVID-19 Media Coverage, In the News